Published in HIV Med on January 21, 2008
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med (2011) 2.08
Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. AIDS Res Hum Retroviruses (2009) 0.92
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. AIDS (2011) 0.91
BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography. PLoS One (2014) 0.90
Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation (2014) 0.87
The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds. Biomed Res Int (2016) 0.79
The initial domestication of goats (Capra hircus) in the Zagros mountains 10,000 years ago. Science (2000) 4.09
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging (2005) 3.61
Usability testing of a prototype Phone Oximeter with healthcare providers in high- and low-medical resource environments. Anaesthesia (2012) 2.77
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science (1997) 2.58
The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen. J Clin Microbiol (1993) 2.21
Effects of passive heating on central blood volume and ventricular dimensions in humans. J Physiol (2007) 2.14
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Evolution of the Borrelia burgdorferi outer surface protein OspC. J Bacteriol (1995) 1.81
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J (Clin Res Ed) (1987) 1.65
Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ (1989) 1.60
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS (1999) 1.58
Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol (1998) 1.47
Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med (1987) 1.46
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis (1998) 1.43
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study. HIV Med (2009) 1.42
Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release. Hepatology (1982) 1.42
Adverse events in nuclear medicine - cause for concern? Eur J Nucl Med Mol Imaging (2012) 1.41
Increased plasma aldosterone during atrial fibrillation declines following cardioversion. Cardiology (2011) 1.40
Zidovudine monotherapy in pregnancy: is it state of the art? HIV Med (2008) 1.40
[Risk factors for the development of asthma in children and adolescents. Results of a longitudinal study]. Ugeskr Laeger (1998) 1.39
The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2006) 1.39
Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg (2008) 1.38
Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS (1993) 1.36
Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella. J Clin Microbiol (1991) 1.36
Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS (1996) 1.32
Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception (1989) 1.29
EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging (2008) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M. Ann Neurol (1991) 1.27
Molluscum contagiosum in HIV-infected patients. Dermatology (1992) 1.25
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med (2000) 1.24
Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology (1993) 1.23
Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J (Clin Res Ed) (1987) 1.22
An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions. J Med Virol (1987) 1.19
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
Serotonin receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol (2003) 1.15
Prevalence of Cryptosporidium among patients with acute enteric infection. J Infect (1984) 1.15
The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology (1987) 1.14
Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability. Eur J Nucl Med (1997) 1.14
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression. J Infect Dis (1998) 1.13
Colloid volume loading does not mitigate decreases in central blood volume during simulated haemorrhage while heat stressed. J Physiol (2012) 1.12
The diagnoses of patients admitted with acute chest pain but without myocardial infarction. Eur Heart J (1996) 1.11
Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis (1992) 1.10
Regional myocardial oxygen consumption estimated by carbon-11 acetate and positron emission tomography before and after repetitive ischemia. J Nucl Cardiol (2000) 1.08
Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging (2006) 1.08
Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol (1994) 1.08
The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab (2008) 1.07
Comparison between two artificial shelter units and timed manual collections for detecting peridomestic Triatoma infestans (Hemiptera: Reduviidae) in rural northwestern Argentina. J Med Entomol (2001) 1.07
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen]. Ugeskr Laeger (1986) 1.06
Adipose tissue lipin expression levels distinguish HIV patients with and without lipodystrophy. Int J Obes (Lond) (2006) 1.06
Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion. J Infect Dis (1998) 1.06
Urbanization and the organization of animal production at Tell Jemmeh in the Middle Bronze Age Levant. J Near East Stud (1988) 1.05
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men. J Infect Dis (1985) 1.04
Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. Scand J Immunol (1986) 1.03
Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta Derm Venereol (1992) 1.02
Widespread use of condoms and low prevalence of sexually transmitted diseases in Danish non-drug addict prostitutes. Br Med J (Clin Res Ed) (1986) 1.02
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy. HIV Med (2009) 1.02
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study. HIV Med (2004) 1.01
Investigations with intravenous bumetanide. Postgrad Med J (1975) 1.01
The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients. AIDS (1987) 1.01
Immune function and phenotype before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (1999) 1.01
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. HIV Med (2009) 1.00
Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study. J Acquir Immune Defic Syndr (1992) 0.99
Effect of portal-systemic anastomosis on renal haemodynamics in cirrhosis. Gut (1976) 0.99
EA-1, a novel adhesion molecule involved in the homing of progenitor T lymphocytes to the thymus. J Cell Biol (1991) 0.99
Bikaverin and norbikaverin, benzoxanthentrione pigments of Gibberella fujikuroi. J Chem Soc Perkin 1 (1971) 0.98
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS (1998) 0.98
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol (2001) 0.98
Uphill running improves rat Achilles tendon tissue mechanical properties and alters gene expression without inducing pathological changes. J Appl Physiol (1985) (2012) 0.97
Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging (2004) 0.97
Systemic two-stage carcinogenesis in the epithelium of the forestomach of mice using 7,12-dimethylbenz(a)anthracene as initiator and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter. Cancer Res (1979) 0.97
Catecholamines and exercise. Diabetes (1979) 0.96
Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI). Am J Epidemiol (1995) 0.96
Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail (2001) 0.95
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers. Scand J Immunol (2008) 0.95
Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. AIDS (1999) 0.94
Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection (2012) 0.93
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Serotonergic involvement in stress-induced ACTH release. Brain Res (1998) 0.92
Bumetanide: a new potent diuretic. The effects of a single intravenous dose in patients with congestive heart failure. Dan Med Bull (1974) 0.92
Enhanced sympathetic nervous activity after intravenous propranolol in ischaemic heart disease: plasma noradrenaline splanchnic blood flow and mixed venous oxygen saturation at rest and during exercise. Eur J Clin Invest (1978) 0.92
Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging (2005) 0.92
Reliability of the Modified Ashworth Scale in the assessment of plantarflexor muscle spasticity in patients with traumatic brain injury. Int J Rehabil Res (1996) 0.91
Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008. HIV Med (2010) 0.91